Astigmatism Post-trabeculectomy
The Effect of Trabeculectomy on Astigmatism.
1 other identifier
observational
52
1 country
1
Brief Summary
The aim of this project:
- 1.Confirming the modification in corneal astigmatism after trabeculectomy with MMC and intracameral administration of bevacizumab.
- 2.Medium-term follow up (6 months) of the induced corneal astigmatism.
- 3.Investigating correlations between postoperative astigmatism, particularly with the postoperative IOP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2012
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 24, 2012
CompletedFirst Posted
Study publicly available on registry
October 22, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedDecember 20, 2024
December 1, 2024
10 months
February 24, 2012
December 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in ocular cylinder and axis untill 6 months after trabeculectomy.
Comparing the change in corneal cylinder, axis and IOP before the operation and 1,3 and 6 months after the operation. We will compare these vectors by vector analyses.
pre-operative until 6 months post-operative
Interventions
Filtering surgery to reduce the intra-ocular pressure.
Eligibility Criteria
All patients having a primary trabeculectomy between January and April 2012 for glaucoma that was not adequately controlled with maximal tolerated medical therapy and/or laser therapy.
You may qualify if:
- Primary open angle glaucoma
- Normal tension glaucoma
- Pseudoexfoliation glaucoma
- Pigment dispersion glaucoma
You may not qualify if:
- Patients who refuse to sign the informed consent.
- Patients with primary angle closure glaucoma (PACG).
- Patients younger than 18 years old.
- Other ocular diseases besides glaucoma.
- Significant corneal opacities.
- Refractive error more than + or -6.00 diopters.
- Visual acuity less than 0.05
- Previous intra-ocular surgery (except cataract surgery more than six months preceding the trabeculectomy).
- Laser treatment for glaucoma within 6 months of the surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sint-Raphaël hospital
Leuven, Vlaams-Brabant, 3000, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heleen Delbeke, MD
UZ Leuven
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
February 24, 2012
First Posted
October 22, 2012
Study Start
January 1, 2012
Primary Completion
November 1, 2012
Study Completion
December 1, 2012
Last Updated
December 20, 2024
Record last verified: 2024-12